FDA product code LGD: Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
LGD is the FDA product code for enzyme linked immunoabsorbent assay, toxoplasma gondii. It is a Class II device, regulated under 21 CFR 866.3780 and reviewed by the Microbiology panel. FDA has cleared 106 510(k) submissions under LGD, 4 in the last five years, from 51 different applicants. The average 510(k) review took 155 days (median 122); 216 days on average over the last three years. FDA has posted 7 recalls for LGD devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii |
| Device class | Class II |
| Regulation | 21 CFR 866.3780 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for LGD
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 270 |
| 2022 | 1 | 444 |
| 2024 | 2 | 173 |
| 2025 | 1 | 260 |
Compare with all 510(k) review times · Search every LGD clearance
Top LGD applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Abbott Laboratories | 12 | 2024-08-30 |
| Beckman Coulter, Inc. | 7 | 2025-03-28 |
| Gull Laboratories, Inc. | 6 | 1997-03-24 |
| Labsystems, Inc. | 5 | 1989-02-07 |
| Diamedix Corp. | 4 | 2000-07-07 |
46 more applicants have LGD clearances. See the full list in Caduvo.
Most recent LGD clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K242022 | Beckman Coulter, Inc. | Access Toxo IgG | 2025-03-28 | 260 |
| K242095 | Beckman Coulter, Inc. | Access Toxo IgM II | 2024-10-11 | 86 |
| K233932 | Abbott Laboratories | Alinity i Toxo IgM | 2024-08-30 | 260 |
| K210596 | Abbott Laboratories | ARCHITECT Toxo IgG | 2022-05-19 | 444 |
| K162678 | Roche Diagnostics | Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl | 2017-06-23 | 270 |
Recalls for LGD devices
7 product recalls in 6 recall events; 1 initiated in the last five years and 2 still open. Most recent: 2025-05-30.
| Year | Recalls |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Frequently asked questions
What is FDA product code LGD?
LGD is the FDA product code for enzyme linked immunoabsorbent assay, toxoplasma gondii. It is a Class II device, regulated under 21 CFR 866.3780 and reviewed by the Microbiology panel.
What device class is LGD?
Class II, regulation 21 CFR 866.3780. Typical premarket route: 510(k).
How long does a 510(k) take for product code LGD?
Across 106 cleared submissions the average was 155 days from receipt to decision (median 122).
Which companies have the most LGD clearances?
Abbott Laboratories (12); Beckman Coulter, Inc. (7); Gull Laboratories, Inc. (6); Labsystems, Inc. (5); Diamedix Corp. (4).
Have LGD devices been recalled?
Yes: 7 product recalls across 6 recall events; the most recent began 2025-05-30.
Next steps
- Run an FDA pathway report with predicate devices for product code LGD
- Run a recall and safety report across every LGD manufacturer
- Watch product code LGD for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times